Skip to content
Use caution Drug recall · FDA · Published May 29, 2014

Teva Recalls Fluvastatin 20mg Capsules Due to Breakage

Teva Pharmaceuticals is recalling one lot of Fluvastatin Capsules USP, 20 mg due to capsule breakage. Check your bottle's lot number and expiration date.

🇺🇸 FDA recall #D-1430-2014DrugTeva Pharmaceuticals ›
Take action

Contact the company

Recalling firmTeva Pharmaceuticals USA1090 Horsham Rd · North Wales, PA 19454-1505
✎ GovInfoNow plain-language explainer

Teva Pharmaceuticals USA has voluntarily recalled a single lot of Fluvastatin Capsules USP, 20 mg because customers reported that the capsules were breaking. This issue affects one specific batch distributed nationwide and in U.S. territories. The recall was initiated on May 29, 2014. Read more at govinfonow.com/recall/46024-teva-pharmaceuticals-usa-recalls-fluvastatin-capsules-usp-20-mg-rx.

Source Summary by GovInfoNow · govinfonow.com/recall/46024-teva-pharmaceuticals-usa-recalls-fluvastatin-capsules-usp-20-mg-rx · Updated October 12, 2026 · FDA enforcement record: FDA #D-1430-2014

Cite this page

“Teva Recalls Fluvastatin 20mg Capsules Due to Breakage.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/46024-teva-pharmaceuticals-usa-recalls-fluvastatin-capsules-usp-20-mg-rx. Based on FDA recall #D-1430-2014 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1430-2014%22&limit=1).

The FDA announced on May 29, 2014, that Teva Pharmaceuticals USA is voluntarily recalling one lot of Fluvastatin Capsules USP, 20 mg due to capsule breakage. The recall affects Lot F47008 distributed nationwide and in U.S. territories.

How to tell if you have it

  • Brand: Teva Pharmaceuticals
  • Product: Fluvastatin Capsules 20 mg
  • NDC: 0093-7442-56
  • Lot #: F47008
  • Expiration: 7/2015
  • Packaging: 30-count bottle
  • Quantity: 8,472 bottles

The hazard

The recall is due to a customer complaint trend regarding capsule breakage. The product failed tablet/capsule specifications.

Context

GovInfoNow's records show Teva Pharmaceuticals USA has 97 other recalls on record since October 11, 2013. Recent recalls include the January 18, 2022, Teva Doxylamine Succinate Tablets Recall for failed dissolution risk and the January 10, 2022, Teva Tretinoin Capsules 10mg Recall for failed dissolution testing. Other recent recalls of similar products include the January 29, 2026, Teva Recalls Metoprolol Succinate 50 mg Due to Dissolution Failure and the April 6, 2026, Teva Recalls Claravis 10mg Due to Impurity Issues.

How to tell if you have this one

Look for a 30-count bottle of Fluvastatin Capsules USP, 20 mg, Rx Only. The specific recalled item has NDC 0093-7442-56, Lot # F47008, and an expiration date of 7/2015.

  • Brand
    Teva Pharmaceuticals
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Your Bottle

    Verify if your bottle matches NDC 0093-7442-56, Lot # F47008, and Exp. 7/2015.

  2. Contact Your Pharmacist

    If you have the recalled lot, contact your pharmacy or healthcare provider for instructions on replacement or disposal.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFLPuerto Rico: yesPR

FDA distribution: “Nationwide and Guam, Puerto Rico, American Samoa, Virgin Islands” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 9 months after the firm started it.

1. Firm started the recall: May 29, 201412. FDA classified it Class II: Jul 10, 201423. Published in FDA’s Enforcement Report: Jul 16, 201434. FDA terminated the recall: Mar 9, 2015420142015
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1430-2014 (May 29, 2014) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1430-2014 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA